NEW YORK (360Dx) – Abbott-owned company Alere and its subsidiary Alere San Diego will pay the US $33.2 million to settle allegations that it caused hospitals to submit false claims to federal healthcare programs by knowingly selling unreliable point-of-care diagnostic testing devices, the US Department of Justice announced on Friday.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
26
Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.